Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Non-Current Deffered Revenue (2017 - 2020)

CV Sciences' Non-Current Deffered Revenue history spans 3 years, with the latest figure at $1.5 million for Q4 2020.

  • For Q4 2020, Non-Current Deffered Revenue changed N/A year-over-year to $1.5 million; the TTM value through Dec 2020 reached $1.5 million, changed N/A, while the annual FY2020 figure was $1.5 million, N/A changed from the prior year.
  • Non-Current Deffered Revenue for Q4 2020 was $1.5 million at CV Sciences, up from $1.3 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $1.5 million in Q4 2020 and bottomed at $1.1 million in Q4 2017.
  • The 3-year median for Non-Current Deffered Revenue is $1.3 million (2018), against an average of $1.3 million.
  • The largest YoY upside for Non-Current Deffered Revenue was 24.44% in 2018 against a maximum downside of 24.44% in 2018.
  • A 3-year view of Non-Current Deffered Revenue shows it stood at $1.1 million in 2017, then increased by 24.44% to $1.3 million in 2018, then grew by 9.33% to $1.5 million in 2020.
  • Per Business Quant, the three most recent readings for CVSI's Non-Current Deffered Revenue are $1.5 million (Q4 2020), $1.3 million (Q4 2018), and $1.1 million (Q4 2017).